{
    "id": 29137,
    "fullName": "PCMTD1 - CCNL2",
    "impact": "fusion",
    "proteinEffect": "loss of function - predicted",
    "geneVariantDescriptions": [
        {
            "description": "PCMTD1-CCNL2 results from the fusion of PCMTD1 and CCNL2 (PMID: 29633253). PCMTD1-CCNL2 has been identified in endometrioid ovarian carcinoma (PMID: 29633253) and is predicted to lead to a loss of function due the the loss of cyclin binding domain in CCNL2 (PMID: 29633253).",
            "references": [
                {
                    "id": 13373,
                    "pubMedId": 29633253,
                    "title": "Identification of novel cyclin gene fusion transcripts in endometrioid ovarian carcinomas.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/29633253"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 115294,
        "geneSymbol": "PCMTD1",
        "terms": [
            "PCMTD1"
        ]
    },
    "variant": "PCMTD1 - CCNL2",
    "createDate": "12/28/2018",
    "updateDate": "10/31/2019",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        {
            "gene": {
                "id": 81669,
                "geneSymbol": "CCNL2",
                "terms": [
                    "CCNL2",
                    "ANIA-6B",
                    "CCNM",
                    "CCNS",
                    "HCLA-ISO",
                    "HLA-ISO",
                    "PCEE",
                    "SB138"
                ]
            }
        }
    ],
    "evidence": [
        
    ],
    "molecularProfiles": [
        {
            "id": 31066,
            "profileName": "PCMTD1 - CCNL2",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}